Francesca Mallamaci, Claudia Torino, Pantelis Sarafidis, Robert Ekart, Charalampos Loutradis, Kostas Siamopoulos, Antonio Del Giudice, Filippo Aucella, Massimo Morosetti, Vasilios Raptis, Athanasios Bikos, Aikaterini Papagianni, Olga Balafa, Efthymios Pappas, Rocco Tripepi, Carmela Marino, Giovanni Tripepi, Charles Ferro, Jolanta Malyszko, Friedo W Dekker, Kitty J Jager, Gérard M London, Carmine Zoccali
BACKGROUND: Uncontrolled hypertension notwithstanding the use of at least three drugs or hypertension controlled with at least four drugs, the widely accepted definition of treatment-resistant hypertension (TRH), is considered as a common problem in the hemodialysis population. However, to date there is no estimate of the prevalence of this condition in hemodialysis patients. METHOD: We estimated the prevalence of TRH by 44-h ambulatory BP monitoring (ABPM) in 506 hemodialysis patients in 10 renal units in Europe included in the registry of the European Renal and Cardiovascular Medicine (EURECAm,), a working group of the European Association, European Dialysis and Transplantation Association (ERA EDTA)...
September 2020: Journal of Hypertension